TwoStep Therapeutics
CA - San CarlosBiotechnology
Focus: TwoStep Therapeutics is a San Carlos-based biotech focused on PIP (Phosphoinositide 3-kinase Inhibitor Prodrugs) therapies in oncology, operating at a pre-revenue stage with minimal disclosed scale.
Profile data last refreshed 6h ago · AI intelligence enriched 2mo ago
Open Jobs
1
Should You Work at TwoStep Therapeutics?
AI assessmentAttractive for early-stage, high-risk tolerant scientists willing to build an oncology platform from scratch, but substantial clarity on clinical evidence and funding is needed before committing.
Why Work Here
- Focused oncology platform: Specialized in an emerging modality (PIP therapies) with potential for differentiated mechanism-of-action advantage in a large market.
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Phase 1
Clinical Trials (1)
NCT07814248A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
Phase 1Help build intelligence for TwoStep Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.